Name: Lumos Diagnostics Holdings (LDX) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

LDX

Health Care Equipment & Services

Lumos Diagnostics Holdings

Short interest: 0.00%; 0.00 pp 30d; as of 8 Oct 2026
Reported shorts: 6K
Shares on issue: 971.666M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Lumos Diagnostics Holdings

Lumos Diagnostics Holdings specializes in the development, manufacture, and distribution of point-of-care diagnostic tests and associated readers. The company is positioned as a leader in rapid diagnostics, offering unique solutions like FebriDx, which aids in differentiating bacterial from viral infections at the point of care.

Company profile →

Lumos Diagnostics Holdings (ASX:LDX) has 0.00% of its shares on issue reported as short positions as of 8 Oct 2026, or about 5,968 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.87% in June 2022. LDX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads LDX today

Zanger BreakoutWatchScore 7rank 1850 of 1942
CAN SLIMNot a candidate
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutWatchScore 10rank 921 of 1502
Quality compoundersWatchScore 22rank 671 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

LDX fundamentals

In the year to 30 Jun 2026, Lumos Diagnostics Holdings (ASX:LDX) recorded revenue of US$13.2M and a net loss after tax of US$5.0M. A year earlier it recorded revenue of US$12.5M and a net loss after tax of US$7.2M. Year-on-year growth: revenue +5.5% (FY). Net margin −37.5%, return on equity −34.1% (FY). Figures are in USD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →